Actym Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Actym Therapeutics's estimated annual revenue is currently $2.5M per year.
- Actym Therapeutics's estimated revenue per employee is $155,000
- Actym Therapeutics's total funding is $60M.
Employee Data
- Actym Therapeutics has 16 Employees.
- Actym Therapeutics grew their employee count by 0% last year.
Actym Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Executive Director, Head Finance & Accounting | Reveal Email/Phone |
3 | Chief Medical Advisor | Reveal Email/Phone |
4 | Chief Scientific Officer | Reveal Email/Phone |
5 | Chief Scientific Officer | Reveal Email/Phone |
6 | SVP Clinical Development | Reveal Email/Phone |
7 | Head Clinical Operations | Reveal Email/Phone |
8 | Head Project Management | Reveal Email/Phone |
9 | Associate Research Fellow (Director) Group Leader | Reveal Email/Phone |
10 | Associate Director, Process Development and Manufacturing | Reveal Email/Phone |
Actym Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.7M | 24 | -8% | N/A | N/A |
What Is Actym Therapeutics?
Actym Therapeutics is a cutting-edge biotech focused on the discovery and development of novel immuno-oncology therapies.
keywords:N/A$60M
Total Funding
16
Number of Employees
$2.5M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Actym Therapeutics News
2022-03-22 - Actym Therapeutics and Wacker Biotech Sign ...
Actym Therapeutics, which focuses on the discovery and development of novel therapies intended for the treatment of cancer, and Wacker...
2022-03-22 - Actym Therapeutics and Wacker Biotech Sign Manufacturing ...
Actym Therapeutics, Inc., based in Berkeley, CA, USA, is a privately-held biotechnology company focused on discovery and development of novel...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.4M | 16 | -36% | N/A |
#2 | $1.3M | 16 | -6% | N/A |
#3 | $0.5M | 16 | -11% | $4M |
#4 | $1.7M | 16 | 33% | N/A |
#5 | $1.4M | 16 | 14% | N/A |